MNPR NASDAQ · Healthcare · FY 2025-12-31

Monopar Therapeutics

0.029.358.587.8117.0ABVfair 20.60buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 108.35 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
108.35 USD
Market cap
725.1M USD
P / B
5.26
P / E
EPS
-1.850
DPS / yield
(0.0%)
NAV / share
20.595
Graham number
Z'' score
53.62
Piotroski F
3 / 9
Beneish M
ROIC vs WACC
-20.0% vs 14.1%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.